Showing results for "BioScrip"
business
BioScrip Reached Proposed Settlement With DOJBioScrip reaches proposed agreement with DOJ to settle claims under False Claims Act, relating to distribution of Novartis Pharmaceutical’s Exjade. Settlement proposed $15m payment, stipulated statement of facts BIOS doesn’t admit liability, doesn’t see futher claimsDecember 16, 2013